Introduction Flashcards

1
Q

Drug

A

Substance used in treatment, diagnosis, prevention, or mitigation of disease
- endogenous or xenobiotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pharmacology

A

Science dealing with the properties of drugs and their effects on living systems
- properties and reactions of drugs especially with relation to their therapeutic value

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pharmacy

A

Separate and complementary health-care profession concerned with collection, preparation, standardization, and dispensing of drugs
- art of preparing, preserving, compounding, and dispensing drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical pharmacology

A

Branch of pharmacology dealing with effectiveness and safety of drugs in the clinical setting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Dose

A

Amount of drug given at one time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What 4 components are needed to write a dosage?

A

Amount of drug given (dose), route of administration, interval between doses, and duration of therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Potency

A

Measurement of biological activity

  • amount of drug needed to achieve a specified biological effect
  • is not medically significant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Efficacy

A

Ability of a drug to control or cure and illness

  • maximal response that can be elicited by a drug
  • effectiveness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Vehicle

A

Carrier or inert medium used as a solvent (or diluent) in which the medicinally active agent is formulated and or administered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Excipients and binders

A

Inert substances added to a formulation in order to provide suitable consistency to the dosage form
- ex: binder, matrix, base or diluent in pills, tablets, creams, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the difference between excipients and binders?

A
  • excipient: prevents gumming of machinery that makes the tablet
  • binder: helps hold the tablet together
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Most of the actual mass of a tablet is _____

A

Inert

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ADME

A

Disposition of a drug as described by its absorption, distribution, metabolism, and excretion

  • qualitative measure
  • ex: pharmacokinetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pharmacokinetics

A

Mathematical description of drug disposition in the body

  • ex: half life, volume of distribution
  • relates drug dose to plasma concentration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pharmacodynamics

A

Relates drug concentration to effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tolerance

A

Responsiveness decreases with continued drug administration

- down regulation of receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Tachyphylaxis

A

Rapid development of tolerance

- down regulation of receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Trade name

A

Proper noun identifying a company’s version of that drug

- is always capitalized!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Official name

A

Nonproprietary, referred to as the generic name

- not capitalized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Type A adverse reaction

A

Adverse event that can be anticipated based on the known mechanism of the drug
- is usually dose dependent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Type B adverse reaction

A

Adverse event that is idiosyncratic, unpredictable, and often nondose-dependent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Therapeutic index

A

Margin of safety, qualitative description

  • difference between effective dose and lethal dose
  • want a greater difference, or a high therapeutic index
23
Q

Extra label drug use

A

Use of a drug in a species, route, dosage, or indication other than indicated on the label
- allowed only by veterinarians and the guidelines of the Animal Medicinal Drug Use Clarification Act

24
Q

Clinical trial

A

Study to establish the safety and efficacy of a drug compared to a placebo or an established treatment

25
Placebo
Substance or treatment with no active therapeutic effect given to deceive the recipient into thinking that it is an active treatment - accounts for 50% of benefit, so you must have a placebo in a clinical trial as a control
26
Placebo effect
A beneficial health outcome resulting from a person's anticipation that an intervention will help them - commonly seen in owners
27
Solution
Homogenous mixtures formed by the mixing of a solid, liquid, or gaseous substance (solute) with a liquid (solvent) - drug is actually dissolved completely - can go IV or other routes
28
Suspension
Colloids with a liquid continuous phase and solid dispersed phase - water-insoluble drugs may be given as suspensions - do not need to be mixed prior to use - NEVER give IV!!
29
Emulsion
Colloids of 2 immiscible liquids where either phase may be either fatty or aqueous - lipid-in-water emulsions are usually liquid - water-in-lipid emulsions are creams - some can go IV, some can't - ex: propofol - add emulsions to prevent separation of oil and water
30
Agonist
Substance binding to a receptor that induces a physiologic action - aka: pressor, mimetic
31
Antagonist
Substance binding to a receptor that blocks the action of an agonist - alters tone, does not cause an effect in itself - aka: blocker, lytic
32
Are there endogenous antagonists?
No, are always referring to a drug given exogenously
33
Physiologic antagonist
Occurs when drugs are antagonistic because of opposing effects at different receptors - both are agonists, but they are opposing in action - ex: allergic reactions and histamine release
34
Competitive antagonists
Constant release and reattachment of both agonist and antagonist - magnitude of the effect is dependent on the amount of drug present and the affinity constant (rate of binding and release) of that drug for the receptor
35
Noncompetitive antagonists
Permanently bind to the receptor - new receptor must be created - rare
36
Dose-response curve
A competitive antagonist can be overcome by adding more agonist - lower dose: no response - max dose: all receptors are occupied, so giving more drug will have no effect
37
Peak concentration
Highest concentration in the drug measured after it is administered before administration of a second dose
38
Trough concentration
Lowest concentration in the drug measured after it is administered
39
LD50
Lethal dose at 50% of animals
40
ED50
Effective dose at 50% of animals
41
Certain safety factor
Alternative to the therapeutic index as an index of safety | - LD1/ED99
42
Minimum effective concentration
Lowest concentration that produces a desired effect | - aka: lowest observed (adverse) effect level (LOEL)
43
Maximum nontoxic dose
MNTD, highest dose that does not produce toxicity | - no observed (adverse) effect level (NOEL)
44
Maximum nontoxic concentration
Highest concentration that does not produce toxicity
45
Partial agonist
Pure agonist blocked | - does not stimulate receptor maximally
46
Trademark symbols
- R: registered trademark, company has exclusive legal right to use trademark - TM: unregistered trademark, limited legal status but notifies public the company considers this name as their property
47
What is the purpose of an injectable formulation?
To change the water solubility of a drug and its absorption characteristics
48
What is the speed of onset for a drug with receptors located in the nucleus?
Slow or delayed onset (hours) due to creation of regulatory proteins - ex: steroids
49
The magnitude of the effect of a drug is dependent on what 2 properties?
The amount of the drug present and the affinity constant (rate of binding and release) of that drug for the receptor - the longer it attaches, the longer the effect - is true for competitive antagonists
50
Additive
Summation of effects of 2 drugs | - ex: use one drug to treat gram pos and one to treat gram neg bacteria
51
Synergistic
2+2=5 - ex: a combo drug used as an antibiotic that is used to treat bacteria sensitive to the combo drug but resistant to each individual drug
52
Antagonistic combo drug
One drug antagonizes the action of the other
53
Assuming a “normal distribution”, state the percentage of that population that would be expected to be encompassed by 1, 2, and 3 standard deviations from the mean response
1 - 68.2% 2- 95.4% 3 - 99.7%
54
Explain why the concentration of a drug might be stated in “units per ml” rather than “mg per ml”
A unit is a measurement of biological activity (usually hormones, heparin, etc) - most liquids are measured in mg/ml